Last-resort drug offered to brain cancer patients with no options left
Disease control
NO_LONGER_AVAILABLE
This program provides an experimental drug called gallium maltolate (GaM) to adults with glioblastoma, a severe brain cancer, that has returned or not responded to standard treatments. It is for patients aged 18 and older who have run out of other options and may still benefit. T…
Sponsor: Imaging Biometrics, LLC • Aim: Disease control
Last updated Apr 30, 2026 15:59 UTC